Buy & Sell Indofarma Tbk. - INAF Share Price Today
Quarterly
Yearly
Income Statement
Revenue
Net Profit
Net Loss
Profit margin %
Q3
’24
Q4
’24
Q1
’25
Q2
’25
Q3
’25
| Item | Q3 2025 | Y/Y Change |
| Revenue | Rp133.74B | -3% |
| Cost of Revenue | Rp145.31B | -2.91% |
| Gross Profit | -Rp11.57B | -1.92% |
| General Expenses, Depreciation, Interest | Rp100.94B | -16.09% |
| Operating Profit | -Rp112.52B | -14.82% |
| Other Income | -Rp5.98B | -345.2% |
| EBT | -Rp118.5B | -29.11% |
| Taxes | -Rp8.59B | -1374.24% |
| Net Income | -Rp127.09B | -23.66% |
Balance Sheet
Assets
Liabilities
Debt to Asset %
Q3
’24
Q4
’24
Q1
’25
Q2
’25
Q3
’25
| Item | Q3 2025 | Y/Y Change |
| Total Assets | Rp581.56B | -23.32% |
| Total Liabilities | Rp1.47T | -14.84% |
| Total Equity | -Rp890.94B | -8.21% |
| Total Liabilities & Total Equity | Rp581.56B | -23.32% |
Cash Flow
Operating
Investing
Finance
Net CF
Q3
’24
Q4
’24
Q1
’25
Q2
’25
Q3
’25
| Item | Q3 2025 | Y/Y Change |
| CF from Operations | Rp179.35B | +222.23% |
| CF from Investment | Rp70.79M | -120.71% |
| CF from Financing | Rp204.68B | +338.75% |
| Net Cash Flow | Rp25.4B | -371.7% |